top of page
More than 25 programs in development
We are committed to developing new therapies and solutions for a wide range of patients in different fields. Rafarma Pharmaceuticals group of companies has run more than 25 programs in several areas, including molecular biology, nuclear medicine, immunology, sustainable packaging, and others.




KEY AREAS

Information disclosure
(SEC Disclosures)
Quotes
(OTC Markets Group)
Financial results
(Finance Yahoo.com)
Reports

RAFARMA PHARMACEUTICALS
group of companies



bottom of page